The ESG Weekly: Should investors care about antibiotic resistance? And only a handful of companies are preventing a deforestation‐free supply chain for the week of November 18.
ESG now11/22/19 • 14 min
Two stories this week with ESG glasses: Antibiotic resistance ‐ the ability of germs to defeat the drugs designed to kill them ‐ is one of the greatest public health challenges of our time; but as the crisis grows what will happen to the companies that produce antibiotics (0:54)? And then Mario Lopez‐Alcala tells us which companies are slowing the transition to a deforestation free supply chain in South America (10:17), all through an ESG lens.
11/22/19 • 14 min
Generate a badge
Get a badge for your website that links back to this episode
Select type & size
<a href="https://goodpods.com/podcasts/esg-now-175936/the-esg-weekly-should-investors-care-about-antibiotic-resistance-and-o-17451578"> <img src="https://storage.googleapis.com/goodpods-images-bucket/badges/generic-badge-1.svg" alt="listen to the esg weekly: should investors care about antibiotic resistance? and only a handful of companies are preventing a deforestation‐free supply chain for the week of november 18. on goodpods" style="width: 225px" /> </a>
Copy